Abstract
We describe a patient who within 2 months of undergoing radio-chemotherapy for glioblastoma developed an Epstein–Barr virus-positive primary diffuse large B-cell CNS lymphoma. To our knowledge, this is the first such case reported in the literature showing that new tumefactions following aggressive treatment for glioblastomata might represent secondary malignancies.
Acknowledgements
We would like to thank our patient's family. We gratefully acknowledge Professor Michael Farrell's help in diagnostic discussions and in carrying out EBV identification.
Declaration of interest: The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.